Inari Medical is a medical device company. Co.'s product offerings consist of two minimally-invasive, catheter-based mechanical thrombectomy systems for the specific characteristics of the venous system and the treatment of the two distinct manifestations of venous thromboembolism, deep vein thrombosis, or DVT, and pulmonary embolism. Co.'s solutions include: ClotTriever System, which is a mechanical thrombectomy system designed to core, capture and remove clots from vessels and is used to treat DVT; FlowTriever System, which is a bore catheter-based aspiration and mechanical thrombectomy system; and ancillary products, which include FlowSaver, FlowStasis, and FlowTriever 2. We show 16 historical shares outstanding datapoints in our coverage of NARI's shares outstanding history.
Understanding the changing numbers of NARI shares outstanding — and
comprehending the concept of differing number of shares outstanding in general comparing companies like NARI versus peers —
is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies.
Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history.
With this page we aim to empower investors researching NARI by allowing them to research NARI shares outstanding history
as well as any other stock in our coverage universe. |
Free NARI Email Alerts:
Video: Shares Outstanding Importance
